The New Drug Research and Development Center is researching and developing new drugs and
new drug targets utilizing epigenetic modification mechanisms for Cancer and cardio-cerebrovascular diseases and dementia.
Brain cancer, breast cancer, lymph cancer
Development of treatment for intractable carcinoma
Vascular Cognitive Impairment (VCI)
Stroke / Transient ischemic Attack (TIA)
Alzheimer’s Disease / Parkinson’s Disease
EDGC New Drug R&D Center conducts researches with the goal to
make possible from diagnosis to care through genomic diagnosis and new drug development for cancer and neuro diseases.
Cancer is well known as a disease caused by abnormalities in the immune system from stress, poor diet and lifestyle and is one of the most feared diseases.
In order to overcome cancer, EDGC New Drug R&D Center is undergoing efforts to develop targeted anticancer drugs and new drugs that can maximize their efficacy as therapeutics of various cancers including intractable cancers.
- Combination Anticancer
- Targeted Anticancer
As our society is aging, the number of patients with stress and degenerated-related cardiovascular and cerebrovascular diseases is steadily increasing.
Cardio-cerebrovascular disease is the leading cause of death in Korea besides cancer. The New Drug R&D Center is developing cures for stroke and neurodegenerative diseases through finding new drug targets and developing new chemicals.
- Vascular Dementia
- Frontotemporal Dementia